DB17699InvestigationalGene Therapies
DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector encoding the human Factor Ix gene. It was previously investigated for the treatment of hemophilia B;...
- Also known as
- AAVrh10FIX
- Code names
- DTX-101
What you can answer from here — as of September 25, 2025
Which companies are running trials of DTX-101, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account